Over 11.5 mn Covid-19 vaccine doses still available with states/UTs: Centre

India has overtaken the United States of America in the total number of vaccine doses administered so far.

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
ANI General News
2 min read Last Updated : Jun 28 2021 | 1:57 PM IST

More than 1.15 crore doses of COVID-19 vaccines are still available with states and union territories, the union health ministry informed on Monday.

States and UTs currently have 1,15,22,543 vaccine doses.

More than 31.69 crores (31,69,40,160) free vaccine doses have been provided by the Centre to states so far through the direct state procurement category.

Of this, the total consumption, including wastages is 30,54,17,617 doses, as of 8 am on Monday.

In a significant COVID-19 vaccination milestone, India has overtaken the United States of America in the total number of vaccine doses administered so far. As many as 32,36,63,297 doses have been administered in India since the vaccination drive started on January 16.

"More than 1.15 crore (1,15,22,543) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered," a statement by the health ministry said.

India is currently witnessing what has been called the 'world's largest vaccination drive'. 75 per cent of all vaccines are being procured by the Centre and given freely to states for distribution.

As many as 46,148 fresh COVID-19 cases were reported in the last 24 hours in India. Active cases have further declined to 5,72,994.

Daily recoveries continued to outnumber the daily new cases for the 46th consecutive day, with 58,578 recoveries in the last 24 hours, dropping the active caseload down to 5,72,994.

The cumulative tally of positive COVID-19 cases in the country stands at 3,02,79,331, including 2,93,09,607 recoveries and 3,96,730 deaths.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 28 2021 | 1:54 PM IST

Next Story